Anebulo Pharmaceuticals (ANEB) News Today $0.29 0.00 (0.00%) As of 10/23/2026 09:30 AM Eastern Add Compare Share Share News and Trends Stock AnalysisChartEarningsFinancialsNews and TrendsSEC Filings Anebulo Pharmaceuticals Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc (ANEB) Stock Price, Quote, News & HistoryJuly 1, 2026 | benzinga.comAnebulo’s Selonabant Phase 1 Completion: What Investors Should Watch NextMay 8, 2026 | tipranks.comAnebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent UpdatesFebruary 13, 2026 | finance.yahoo.comAnebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plansFebruary 6, 2026 | in.investing.comAnebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SECFebruary 6, 2026 | finance.yahoo.comAnebulo Pharmaceuticals Announces Final Results of Tender OfferJanuary 29, 2026 | finance.yahoo.comAnebulo Pharmaceuticals Announces Preliminary Results of Tender OfferJanuary 27, 2026 | businesswire.comAnebulo announces cash tender offer of 300,000 shares at $3.50 per shareDecember 22, 2025 | msn.comAnebulo Pharmaceuticals stock plunges after scrapping reverse split planDecember 22, 2025 | za.investing.comAnebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender OfferDecember 22, 2025 | businesswire.comAnebulo Pharmaceuticals reports Q1 EPS (5c), one estimate (12c)November 13, 2025 | msn.comAnebulo Pharmaceuticals Reports Q1 2026 Financial ResultsNovember 13, 2025 | tipranks.comAnebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent UpdatesNovember 13, 2025 | businesswire.comAnebulo Pharmaceuticals’ Selonabant Study: Key Insights for InvestorsOctober 27, 2025 | tipranks.comAnebulo Pharmaceuticals’ Bold Move: Potential Risks of Going Private with Reverse Stock SplitOctober 2, 2025 | msn.comAnebulo Pharmaceuticals Advances Cannabis Toxicity TreatmentOctober 1, 2025 | msn.comAnebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent UpdatesSeptember 29, 2025 | businesswire.comAnebulo begins Phase I trial of IV cannabis antidoteSeptember 26, 2025 | msn.comAnebulo Pharmaceuticals doses first subjects in selonabant studySeptember 25, 2025 | msn.comAnebulo Pharmaceuticals provides update on going private transactionSeptember 12, 2025 | msn.comAnebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic AlternativesSeptember 12, 2025 | businesswire.comCannabis Use Disorder (CUD) Pipeline Market Research Report 2025 Featuring Aelis Farma, Anebulo Pharmaceuticals, and IndiviorJuly 25, 2025 | finance.yahoo.comMaxim Group Downgrades Anebulo Pharmaceuticals (ANEB)July 25, 2025 | msn.comAnebulo Pharmaceuticals stock soars after approving plan to go privateJuly 23, 2025 | investing.comAnebulo Pharmaceuticals shares surge 80% after board approves plan to go privateJuly 23, 2025 | msn.comAnebulo approves reverse stock split ahead of going-private transactionJuly 23, 2025 | msn.comAnebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent UpdatesMay 13, 2025 | businesswire.comHere's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn SituationApril 27, 2025 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS) and Stoke Therapeutics (STOK)March 19, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), BioLife Solutions (BLFS) and Surgery Partners (SGRY)March 4, 2025 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Anebulo Pharmaceuticals (ANEB) and AMN Healthcare Services (AMN)February 25, 2025 | markets.businessinsider.comAnebulo Pharmaceuticals files to sell 15.15M shares of common stock for holdersFebruary 20, 2025 | markets.businessinsider.comAnebulo Pharmaceuticals reports Q4 EPS (9c) vs. (11c) last yearFebruary 14, 2025 | markets.businessinsider.comAnebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent UpdatesFebruary 14, 2025 | businesswire.comAnebulo Pharmaceuticals sets annual meeting for April 4, 2025February 12, 2025 | msn.comAnebulo Pharmaceuticals Leads This Trio Of US Penny StocksFebruary 4, 2025 | uk.finance.yahoo.com3 US Penny Stocks With Market Caps Under $800MDecember 30, 2024 | uk.finance.yahoo.comAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Director Purchases $9,999,999.90 in StockDecember 27, 2024 | insidertrades.comAnebulo Pharmaceuticals collaborates with FDA to advance selonabantDecember 24, 2024 | finance.yahoo.comAnebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital RaiseDecember 23, 2024 | businesswire.comAnebulo Pharmaceuticals Advances Cannabis Toxicity SolutionsNovember 15, 2024 | tipranks.comAnebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent UpdatesNovember 13, 2024 | finance.yahoo.comBenchmark maintains Speculative Buy on Anebulo stockOctober 3, 2024 | uk.investing.comAnebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent UpdatesSeptember 25, 2024 | finance.yahoo.comANEB Anebulo Pharmaceuticals, Inc.July 28, 2024 | seekingalpha.comAnebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic EffectsJuly 22, 2024 | businesswire.comANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024May 15, 2024 | investorplace.comAnebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent UpdatesMay 15, 2024 | finance.yahoo.comGalehead Development to Collaborate With Rivian Automotive on Renewable Energy Project DevelopmentMay 15, 2024 | businesswire.comNew Debt & Financing Risk for Anebulo Pharmaceuticals, Inc. – What’s the Latest?February 15, 2024 | msn.com Anebulo Pharmaceuticals Media Mentions By Week Anebulo Pharmaceuticals Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANEB News Sentiment▼0.000.47▲Average Healthcare News Sentiment Anebulo Pharmaceuticals News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANEB Articles This Week▼01▲ANEB Articles Average Week Get Anebulo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANEB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Caribou Biosciences News iBio News Yarrow Bioscience News Werewolf Therapeutics News ImageneBio News Elicio Therapeutics News Adicet Bio News INmune Bio News Tevogen Bio News Celularity News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Anebulo Pharmaceuticals dated 7/1/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
